Investment
Features
FeesSafety
Academy
More
Pluang+

Satellogic posts 259% revenue growth, first positive operating income in Q2 2026, advancing AI satellite projects.

Company Fundamentals
05 Aug 2026
GlobeNewsWire
View Source
Bullish
Satellogic posts 259% revenue growth, first positive operating income in Q2 2026, advancing AI satellite projects.

Satellogic reported a 259% year-over-year revenue increase to $15.9 million in Q2 2026, achieving its first quarter of positive operating income and adjusted EBITDA. The company expanded its satellite delivery contracts, including a $12 million deal with a sovereign defense customer, and advanced its AI-driven Merlin satellite constellation, on track for launch in late 2026. With $112.8 million cash and $80.7 million in performance obligations, Satellogic is positioned for growth in global intelligence and defense markets.

More News

Scotiabank raises Targa Resources price target to $319, citing strong momentum and a $1.25 dividend.

Scotiabank raises Targa Resources price target to $319, citing strong momentum and a $1.25 dividend.

Scotiabank increased its price target for Targa Resources to $319 from $314, indicating a potential 12.7% upside from the current share price of around $283. Targa Resources, a key player in the midstream energy sector, is recognized as a top momentu...

Analyst Insights
Bullish
1 hour ago
Ericsson beats Q3 earnings estimates on strong mobile network demand despite margin concerns for 2027

Ericsson beats Q3 earnings estimates on strong mobile network demand despite margin concerns for 2027

Ericsson reported better-than-expected Q3 earnings with EPS of $0.18 and revenue of $5.91 billion, driven by strong demand in its mobile network segment. The Networks division showed 9% organic growth and a gross margin above guidance, but overall op...

Company Fundamentals
Bullish
1 hour ago
Over 200 companies advance next-gen obesity drugs with new therapies and clinical trials surging globally

Over 200 companies advance next-gen obesity drugs with new therapies and clinical trials surging globally

The obesity treatment landscape is rapidly evolving with over 200 companies developing more than 200 pipeline drugs, including late-stage and early-stage clinical trials. Major pharmaceutical firms like Novo Nordisk and Eli Lilly are leading with inn...

Market News
Bullish
1 hour ago
Alice, Inflection AI, and AI21 show NVIDIA Nemotron models can be trained for advanced AI safety and security.

Alice, Inflection AI, and AI21 show NVIDIA Nemotron models can be trained for advanced AI safety and security.

Alice collaborated with Inflection AI and AI21 to demonstrate that NVIDIA Nemotron open models can be post-trained using real-world adversarial data to enhance AI safety and security without losing capability. Inflection AI improved conversational AI...

Market News
Bullish
1 hour ago
Stifel reaffirms Buy on Accenture with $242 target amid strong AI-driven growth and 13.4% stock rise.

Stifel reaffirms Buy on Accenture with $242 target amid strong AI-driven growth and 13.4% stock rise.

Stifel Nicolaus has reiterated a Buy rating for Accenture with a price target of $242, reflecting confidence in the company's strong recent stock performance and growth prospects. Accenture's shares rose 13.4% in the month leading up to October 15, 2...

Analyst Insights
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App